Clusterin in disease pathology
Moving in bioRxiv, Cancer Research, Nature, Nature Cancer, Nature Chemical Biology and Nature Neuroscience.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 6
Add Clusterin in disease pathology as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Clusterin in disease pathology
Newest first · last 60 days
Mitochondrial fission factor phosphorylation at Ser155 drives ferroptosis by promoting organelle fragmentation and oxidative stress in cells.
HSPA6 promotes lenvatinib resistance in hepatocellular carcinoma by stabilizing TXNRD1 through phase separation, reducing ferroptosis, and correlating with poor patient outcomes.
Add Clusterin in disease pathology as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6157
- medRxiv1716
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ200
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Cell Rep130
- Lancet128
- NEJM119
- Curr Biol108
- mBio107
- Plant Cell Environ107
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3